Tag: Hikma Pharmaceuticals

Hikma Reports Strong H1 2026 Results, Reaffirms Full-Year Outlook

Hikma Pharmaceuticals reported 4% revenue growth to $1.728 billion in H1 2026,…

ME Desk

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Pfizer has reached settlement agreements with multiple generic manufacturers over VYNDAMAX (tafamidis),…

ME Desk

Hikma Pharma Joins Naloxone for Fentanyl Awareness Day

London– Hikma Pharmaceuticals in the US joined government officials and non-profit leaders…

ME Desk